"I am hoping if we scoop up 10-15% of the Vyvanse market($400-500M) like I think they will, those proceeds with then be used to buy back 20-25% of the outstanding shares. This in turn will push the stock price to a point where we can uplist organically" !!!!!!!!!!!!!
Now that is a wise plan .... nasrat should follow !!!!!!!!!!!!!
catching up on our best posters! thanks for all your input, Wow, potential revenues for calendar 2025 and beyond is truly what makes elite different from the awaiting all things sequestox,